These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15863327)

  • 1. 5-Lipoxygenase inhibitors: convenient synthesis of 4-[3-(4-heterocyclylphenylthio)phenyl]-3,4,5,6-tetrahydro-2H-pyran-4-carboxamide analogues.
    Mano T; Stevens RW; Okumura Y; Kawai M; Okumura T; Sakakibara M
    Bioorg Med Chem Lett; 2005 May; 15(10):2611-5. PubMed ID: 15863327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-[5-Fluoro-3-[4-(2-methyl-1H-imidazol-1-yl)benzyloxy]phenyl]-3,4,5,6- tetrahydro-2H-pyran-4-carboxamide, an orally active inhibitor of 5-lipoxygenase with improved pharmacokinetic and toxicology characteristics.
    Mano T; Okumura Y; Sakakibara M; Okumura T; Tamura T; Miyamoto K; Stevens RW
    J Med Chem; 2004 Jan; 47(3):720-5. PubMed ID: 14736252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Lipoxygenase inhibitors: synthesis and structure-activity relationships of a series of 1-aryl-2H,4H-tetrahydro-1,2,4-triazin-3-ones.
    Bhatia PA; Brooks CD; Basha A; Ratajczyk JD; Gunn BP; Bouska JB; Lanni C; Young PR; Bell RL; Carter GW
    J Med Chem; 1996 Sep; 39(20):3938-50. PubMed ID: 8831760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and activity relationships leading to the discovery of ICI D2138, a selective, potent and orally active inhibitor of 5-lipoxygenase.
    Crawley GC; Bird TG; Bruneau P; Dowell RI; Edwards PN; Foster SJ; Girodeau JM; McMillan RM; Walker ER; Waterson D
    J Lipid Mediat; 1993; 6(1-3):249-57. PubMed ID: 8395247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and 5-lipoxygenase inhibitory activity of new cinnamoyl and caffeoyl clusters.
    Doiron J; Boudreau LH; Picot N; Villebonet B; Surette ME; Touaibia M
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1118-21. PubMed ID: 19152786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of a novel class of rofecoxib analogues as dual inhibitors of cyclooxygenases (COXs) and lipoxygenases (LOXs).
    Chen QH; Rao PN; Knaus EE
    Bioorg Med Chem; 2006 Dec; 14(23):7898-909. PubMed ID: 16904331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6-substituted purines as inhibitors of 15-lipoxygenase; a structure-activity study.
    Bråthe A; Gundersen LL; Malterud KE; Rise F
    Arch Pharm (Weinheim); 2005 Apr; 338(4):159-66. PubMed ID: 15864785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dioxabicyclooctanyl naphthalenenitriles as nonredox 5-lipoxygenase inhibitors: structure-activity relationship study directed toward the improvement of metabolic stability.
    Delorme D; Ducharme Y; Brideau C; Chan CC; Chauret N; Desmarais S; Dubé D; Falgueyret JP; Fortin R; Guay J; Hamel P; Jones TR; Lépine C; Li C; McAuliffe M; McFarlane CS; Nicoll-Griffith DA; Riendeau D; Yergey JA; Girard Y
    J Med Chem; 1996 Sep; 39(20):3951-70. PubMed ID: 8831761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of a class of 5-benzylidene-2-phenyl-thiazolinones as potent 5-lipoxygenase inhibitors.
    Barzen S; Rödl CB; Lill A; Steinhilber D; Stark H; Hofmann B
    Bioorg Med Chem; 2012 Jun; 20(11):3575-83. PubMed ID: 22551629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and biological evaluation of (E)-3-(4-methanesulfonylphenyl)-2-(aryl)acrylic acids as dual inhibitors of cyclooxygenases and lipoxygenases.
    Moreau A; Chen QH; Praveen Rao PN; Knaus EE
    Bioorg Med Chem; 2006 Dec; 14(23):7716-27. PubMed ID: 16931030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of celecoxib analogues possessing a N-difluoromethyl-1,2-dihydropyrid-2-one 5-lipoxygenase pharmacophore: biological evaluation as dual inhibitors of cyclooxygenases and 5-lipoxygenase with anti-inflammatory activity.
    Chowdhury MA; Abdellatif KR; Dong Y; Das D; Suresh MR; Knaus EE
    J Med Chem; 2009 Mar; 52(6):1525-9. PubMed ID: 19296694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of imidazole 5-lipoxygenase inhibitors and selection and synthesis of a development candidate.
    Mano T; Stevens RW; Ando K; Kawai M; Kawamura K; Nakao K; Okumura Y; Okumura T; Sakakibara M; Miyamoto K; Tamura T
    Chem Pharm Bull (Tokyo); 2005 Aug; 53(8):965-73. PubMed ID: 16079529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A class of 5-benzylidene-2-phenylthiazolinones with high potency as direct 5-lipoxygenase inhibitors.
    Hofmann B; Barzen S; Rödl CB; Kiehl A; Borig J; Zivković A; Stark H; Schneider G; Steinhilber D
    J Med Chem; 2011 Mar; 54(6):1943-7. PubMed ID: 21341744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further structural exploration of trisubstituted asymmetric pyran derivatives (2S,4R,5R)-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol and their corresponding disubstituted (3S,6S) pyran derivatives: a proposed pharmacophore model for high-affinity interaction with the dopamine, serotonin, and norepinephrine transporters.
    Zhang S; Fernandez F; Hazeldine S; Deschamps J; Zhen J; Reith ME; Dutta AK
    J Med Chem; 2006 Jul; 49(14):4239-47. PubMed ID: 16821783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caulerpenyne and related bis-enol esters are novel-type inhibitors of human 5-lipoxygenase.
    Richter P; Schubert G; Schaible AM; Cavas L; Werz O; Pohnert G
    ChemMedChem; 2014 Aug; 9(8):1655-9. PubMed ID: 24729578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SAR-study on a new class of imidazo[1,2-a]pyridine-based inhibitors of 5-lipoxygenase.
    Hieke M; Rödl CB; Wisniewska JM; la Buscató E; Stark H; Schubert-Zsilavecz M; Steinhilber D; Hofmann B; Proschak E
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1969-75. PubMed ID: 22326163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel imidazole compounds as a new series of potent, orally active inhibitors of 5-lipoxygenase.
    Mano T; Stevens RW; Ando K; Nakao K; Okumura Y; Sakakibara M; Okumura T; Tamura T; Miyamoto K
    Bioorg Med Chem; 2003 Sep; 11(18):3879-87. PubMed ID: 12927848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of new sulfonamides as lipoxygenase inhibitors.
    Mustafa G; Khan IU; Ashraf M; Afzal I; Shahzad SA; Shafiq M
    Bioorg Med Chem; 2012 Apr; 20(8):2535-9. PubMed ID: 22436389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoxygenase inhibitors from natural plant sources. Part 1: Medicinal plants with inhibitory activity on arachidonate 5-lipoxygenase and 5-lipoxygenase[sol ]cyclooxygenase.
    Schneider I; Bucar F
    Phytother Res; 2005 Feb; 19(2):81-102. PubMed ID: 15852496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of pyrimido[4,5-b][1,4]benzothiazine derivatives, as potent 15-lipoxygenase inhibitors.
    Bakavoli M; Nikpour M; Rahimizadeh M; Saberi MR; Sadeghian H
    Bioorg Med Chem; 2007 Mar; 15(5):2120-6. PubMed ID: 17210254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.